| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3559972
Max Phase: Preclinical
Molecular Formula: C35H34F6N4O6
Molecular Weight: 492.62
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(NCCN1CCC2(CC1)C(=O)NCN2Cc1cccc2ccccc12)c1ccc2ccccc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C31H32N4O2.2C2HF3O2/c36-29(26-13-12-23-6-1-2-8-25(23)20-26)32-16-19-34-17-14-31(15-18-34)30(37)33-22-35(31)21-27-10-5-9-24-7-3-4-11-28(24)27;2*3-2(4,5)1(6)7/h1-13,20H,14-19,21-22H2,(H,32,36)(H,33,37);2*(H,6,7)
Standard InChI Key: MKLFERIFRRCFIN-UHFFFAOYSA-N
Associated Targets(Human)
Phospholipase D2 437 Activities
Phospholipase D1 469 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 492.62 | Molecular Weight (Monoisotopic): 492.2525 | AlogP: 4.15 | #Rotatable Bonds: 6 |
| Polar Surface Area: 64.68 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.99 | CX Basic pKa: 7.76 | CX LogP: 3.86 | CX LogD: 3.34 |
| Aromatic Rings: 4 | Heavy Atoms: 37 | QED Weighted: 0.42 | Np Likeness Score: -0.84 |
References
| 1. PubChem BioAssay data set, |
Source
Source(1):